Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0000904454-14-000089
Filing Date
2014-01-21
Accepted
2014-01-21 18:06:23
Documents
1
Period of Report
2014-01-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3/A  
1 PRIMARY DOCUMENT edgar.xml 3/A 4269
  Complete submission text file 0000904454-14-000089.txt   5851
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PURE BIOSCIENCE 1725 GILLESPIE WAY EL CAJON CA 92020
Business Address
Johnson Craig A (Reporting) CIK: 0001370348 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-33221 | Film No.: 14538819